BRPI0113372A8 - - Google Patents

Info

Publication number
BRPI0113372A8
BRPI0113372A8 BRPI0113372A BRPI0113372A8 BR PI0113372 A8 BRPI0113372 A8 BR PI0113372A8 BR PI0113372 A BRPI0113372 A BR PI0113372A BR PI0113372 A8 BRPI0113372 A8 BR PI0113372A8
Authority
BR
Brazil
Application number
Other languages
Portuguese (pt)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BRPI0113372A8 publication Critical patent/BRPI0113372A8/pt
Publication of BR0113372A publication Critical patent/BR0113372A/pt
Publication of BRPI0113372B1 publication Critical patent/BRPI0113372B1/pt
Publication of BRPI0113372B8 publication Critical patent/BRPI0113372B8/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BRPI0113372A 2000-09-12 2001-09-07 composição veterinária com veículo modificado e ceftiofur BRPI0113372B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23176700P 2000-09-12 2000-09-12
US60/231.767 2000-09-12
PCT/US2001/026013 WO2002022107A2 (en) 2000-09-12 2001-09-07 Pharmaceutical composition having modified carrier

Publications (4)

Publication Number Publication Date
BRPI0113372A8 true BRPI0113372A8 (US06573293-20030603-C00184.png) 2003-06-24
BR0113372A BR0113372A (pt) 2003-06-24
BRPI0113372B1 BRPI0113372B1 (pt) 2017-08-01
BRPI0113372B8 BRPI0113372B8 (pt) 2021-10-13

Family

ID=22870572

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0113372A BRPI0113372B8 (pt) 2000-09-12 2001-09-07 composição veterinária com veículo modificado e ceftiofur

Country Status (18)

Country Link
US (1) US20020110561A1 (US06573293-20030603-C00184.png)
EP (1) EP1317256B1 (US06573293-20030603-C00184.png)
JP (1) JP4738713B2 (US06573293-20030603-C00184.png)
AR (2) AR030648A1 (US06573293-20030603-C00184.png)
AT (1) ATE412405T1 (US06573293-20030603-C00184.png)
AU (2) AU8832301A (US06573293-20030603-C00184.png)
BR (1) BRPI0113372B8 (US06573293-20030603-C00184.png)
CA (1) CA2416566C (US06573293-20030603-C00184.png)
DE (1) DE60136367D1 (US06573293-20030603-C00184.png)
DK (1) DK1317256T3 (US06573293-20030603-C00184.png)
ES (1) ES2313981T3 (US06573293-20030603-C00184.png)
MX (1) MXPA03002055A (US06573293-20030603-C00184.png)
NZ (1) NZ524694A (US06573293-20030603-C00184.png)
PE (1) PE20030046A1 (US06573293-20030603-C00184.png)
PT (1) PT1317256E (US06573293-20030603-C00184.png)
TW (1) TWI284046B (US06573293-20030603-C00184.png)
WO (1) WO2002022107A2 (US06573293-20030603-C00184.png)
ZA (1) ZA200300617B (US06573293-20030603-C00184.png)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040033938A1 (en) * 2000-09-12 2004-02-19 Britten Nancy J. Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis
KR20040015622A (ko) * 2002-08-13 2004-02-19 대한뉴팜(주) 세프티오푸르나트륨을 활성성분으로 함유하는 현탁주사액조성물
US7659061B2 (en) * 2002-11-19 2010-02-09 Pharmacia & Upjohn Company Pharmaceutical compositions having a modified vehicle
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
US20080153894A1 (en) * 2002-12-19 2008-06-26 Pharmacia Corporation Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis
EP2367572B1 (en) * 2008-11-19 2018-08-29 Merial, Inc. Formulations comprising ceftiofur and benzyl alcohol
BRPI0903778B1 (pt) 2009-07-17 2017-04-18 Cargill Agrícola S A composição alimentícia de gordura vegetal, processo de preparação de uma composição alimentícia de gordura vegetal e uso de uma composição alimentícia de gordura vegetal na preparação de recheio
KR102162901B1 (ko) * 2011-09-29 2020-10-08 피엘엑스 옵코 인코포레이티드 위장관을 따라 약물을 표적화 방출하기 위한 pH 감응성 담체, 그로부터의 조성물, 및 이들의 제조 및 사용 방법
US10772343B2 (en) 2014-11-19 2020-09-15 Kansas State University Research Foundation Chemical mitigants in animal feed and feed ingredients

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100296810B1 (ko) * 1993-03-12 2001-10-24 로렌스 티. 마이젠헬더 결정성세프티오퍼유리산
US5736151A (en) * 1996-12-09 1998-04-07 Pharmacia & Upjohn Company Antibiotic oil suspensions
US6074657A (en) * 1997-03-20 2000-06-13 Pharmacia & Upjohn Company Administration of an injectable antibiotic in the ear of an animal

Also Published As

Publication number Publication date
PT1317256E (pt) 2008-12-17
ATE412405T1 (de) 2008-11-15
AU8832301A (en) 2002-03-26
BR0113372A (pt) 2003-06-24
PE20030046A1 (es) 2003-02-14
ES2313981T3 (es) 2009-03-16
JP2004508395A (ja) 2004-03-18
CA2416566A1 (en) 2002-03-21
TWI284046B (en) 2007-07-21
US20020110561A1 (en) 2002-08-15
EP1317256B1 (en) 2008-10-29
WO2002022107A2 (en) 2002-03-21
DE60136367D1 (de) 2008-12-11
WO2002022107A3 (en) 2003-01-16
AR086688A2 (es) 2014-01-15
NZ524694A (en) 2005-05-27
MXPA03002055A (es) 2004-12-13
DK1317256T3 (da) 2009-01-26
BRPI0113372B1 (pt) 2017-08-01
JP4738713B2 (ja) 2011-08-03
ZA200300617B (en) 2004-04-22
AR030648A1 (es) 2003-08-27
CA2416566C (en) 2011-05-31
BRPI0113372B8 (pt) 2021-10-13
AU2001288323B2 (en) 2006-11-23
EP1317256A2 (en) 2003-06-11

Similar Documents

Publication Publication Date Title
JP2001245868A5 (US06573293-20030603-C00184.png)
JP2002539025A5 (US06573293-20030603-C00184.png)
AU2000236813A8 (US06573293-20030603-C00184.png)
JP2003511167A5 (US06573293-20030603-C00184.png)
JP2001224585A5 (US06573293-20030603-C00184.png)
JP2002023719A5 (US06573293-20030603-C00184.png)
JP2002025989A5 (US06573293-20030603-C00184.png)
JP2002076404A5 (US06573293-20030603-C00184.png)
JP2001260410A5 (US06573293-20030603-C00184.png)
BRPI0113372A8 (US06573293-20030603-C00184.png)
JP2001332010A5 (US06573293-20030603-C00184.png)
JP2001351241A5 (US06573293-20030603-C00184.png)
BY5768C1 (US06573293-20030603-C00184.png)
CN300955183S (zh) 连接件
AU2000256911A8 (US06573293-20030603-C00184.png)
CN3135584S (US06573293-20030603-C00184.png)
CN3145855S (US06573293-20030603-C00184.png)
CN3145103S (US06573293-20030603-C00184.png)
CN3143879S (US06573293-20030603-C00184.png)
CN3142225S (US06573293-20030603-C00184.png)
CN3147660S (US06573293-20030603-C00184.png)
CN3135488S (US06573293-20030603-C00184.png)
CN3148873S (US06573293-20030603-C00184.png)
CN3134543S (US06573293-20030603-C00184.png)
CN3148891S (US06573293-20030603-C00184.png)

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25D Requested change of name of applicant approved

Owner name: PHARMACIA AND UPJOHN COMPANY LLC (US)

B25A Requested transfer of rights approved

Owner name: PAH PANDU LLC (US)

B25D Requested change of name of applicant approved

Owner name: ZOETIS PANDU LLC (US)

B25A Requested transfer of rights approved

Owner name: ZOETIS SERVICES LLC (US)

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 07/09/2001, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REF. RPI 2430 DE 01/08/2017 - PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 01/08/2017, OBSERVADAS AS CONDICOES LEGAIS. JUSTIFICATIVA DE RETIFICACAO: PATENTE RELACIONADA A PRODUTO VETERINARIO.